Gerald Andriole Jr., M.D., is the director of urology in the National Capital Region at the Brady Urologic Institute for Johns Hopkins Medicine. A nationally recognized clinician and researcher, Dr. Andriole has made major contributions to the field of prostate cancer screening and treatment. He established an image-guided prostate biopsy approach using MRI and micro-ultrasound techniques at the Washington University School of Medicine, where he was chief of urologic surgery prior to relocating to Johns Hopkins Medicine.
Dr. Andriole received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania. He trained in surgery at Strong Memorial Hospital at the University of Rochester in New York and completed his urology residency at Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts. Following this, he completed a fellowship in urologic oncology at the National Cancer Institute in Bethesda, Maryland.
Dr. Andriole has over 35 years of consistent contributions in the areas of benign prostatic hyperplasia, and prostate cancer screening and prevention research. He has contributed well over 400 peer-reviewed publications and serves on the editorial boards of several prestigious journals.
He is chairman of the prostate committee of the National Cancer Institute’s Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and principal investigator of the NIDDK Multidisciplinary Approach to Urologic Pelvic Pain (MAPP) and Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). He was chairman of the steering committee of the REDUCE Prostate Cancer Prevention Trial, as well as principal investigator of both the National Institute of Diabetes and Digestive and Kidney Diseases’ Medical Therapy of Prostatic Symptoms (MTOPS) BPH trial and the Complementary and Alternative Medicine for Urinary Symptoms (CAMUS) study.
Dr. Andriole is a member of the American Urological Association, the American Association for Cancer Research, the American Society of Clinical Oncology, the American Surgical Association, the American Association of Genitourinary Surgeons, and the Clinical Society of Genitourinary Surgeons, among other societies.